Cargando…
Application of New Drugs in Chronic Lymphocytic Leukemia
Over the last few years, several new agents have been under evaluation in preclinical studies as well as in early clinical trials, and have shown promise in treating CLL. These treatments include new monoclonal antibodies (mAbs), immunomodulating agents, novel purine nucleoside analogs, Bcl-2 inhibi...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033144/ https://www.ncbi.nlm.nih.gov/pubmed/21415964 http://dx.doi.org/10.4084/MJHID.2010.011 |